DUBLIN , July 21, 2022 /PRNewswire/ -- The "Global Healthcare Additive Manufacturing Market Size, Share & Trends Analysis Report by Technology (Laser Sintering, Deposition Modeling), by Application, by Material, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global healthcare additive manufacturing market size is expected to reach USD 9.9 billion by 2030. It is expected to expand at a CAGR of 22.6% from 2022 to 2030.

The healthcare additive manufacturing technology helps in producing complex designs easily, forming personalized products, eliminating the production step, and producing lightweight products, which, in turn, is fueling the market growth.

Growing commercialization of the manufacturing process, rising investment by the government, and an increase in R&D in devices formed using additive manufacturing are key factors driving this market.

The advantages of additive manufacturing over traditional production methods are driving its growing popularity. The utilization of modern technology, design freedom, dimensional precision, the use of a wide range of materials such as metal, plastics, and polymers, build speed and the capacity to construct complicated parts/geometry, such as cooling channels and honeycomb structure, are just a few of the advantages of additive manufacturing. However, the main use of additive manufacturing in the healthcare industry is the production of implants and prostheses.

The growing geriatric population has led to an increase in orthopedic operations such as knee and hip replacements, which has resulted in the increased demand for the implants and prostheses leading to quicker manufacturing of these products, thus additive manufacturing plays a crucial role to meet the demand.

Healthcare Additive Manufacturing Market Report Highlights

The laser sintering technology segment dominated the market with a revenue share of over 30.0% in 2021. This technology produces high-quality complex geometries in less time, which, in turn, is fueling the segment growth.

Based on application, the medical implants segment accounted for the largest revenue share of over 30.0% in 2021.

By material, polymers accounted for the largest revenue share of over 50.0% in 2021 as polymers reduce the cost of the manufacturing process, are flexible, and have a long life span.

Asia Pacific is projected to register the fastest CAGR of 28.5% during the forecast period. This is due to the unmet needs of a large population and the economic development in the region.

Demand for customized additive manufacturing

High costs associated with Additive Manufacturing

Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. Healthcare Additive Manufacturing Market Variables, Trends & Scope Chapter 4. Healthcare Additive Manufacturing Market: Segment Analysis, by Technology, 2018-2030 (USD Million) Chapter 5. Healthcare Additive Manufacturing Market: Segment Analysis, by Application, 2018-2030 (USD Million) Chapter 6. Healthcare Additive Manufacturing Market: Segment Analysis, by Material, 2018-2030 (USD Million) Chapter 7. Healthcare Additive Manufacturing Market: Regional Market Analysis, by Region, 2018-2030 (USD Million) Chapter 8. Healthcare Additive Manufacturing Market-Competitive Analysis

GPI Prototype and Manufacturing Services, LLC

For more information about this report visit https://www.researchandmarkets.com/r/aprkm4

Media Contact: Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com   For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900   U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-healthcare-additive-manufacturing-market-report-2022-featuring-key-players-ge-additive-regenhu-allevi--others-301590871.html

Yahoo Finance tech editor Dan Howley breaks down Meta's third-quarter results, which were a miss on both the top and bottom line.

Moor Insights & Strategy Founder, Chief Analyst, and CEO Patrick Moorhead sits down with Yahoo Finance Live to react to Qualcomm's third-quarter earnings report and its guidance against competitors in automotive technology.

Yahoo Finance Live breaks down the market reactions to Fed Chair Jerome Powell's press conference announcing a 75 basis-point rate hike.

Shares of Cassava Sciences Inc. (sava) plunged 21.0% in trading on Wednesday after Reuters reported that the Justice Department is investigating whether the company manipulated clinical data for a still-investigational Alzheimer's disease drug, citing people familiar with the matter. Cassava put out a news release in December that said a scientific journal did not find evidence of manipulated data in a 2005 paper authored by the company's scientists after short sellers alleged data manipulation in some previously published research. Cassava's Alzheimer's drug candidate is currently in Phase 3 clinical trials.

Ford reported second quarter financial results after the bell on Wednesday easily topping estimates on both the top and bottom lines, and reaffirming its full-year profit guidance.

After 2022’s calamitous first half, despite the recent choppiness, July is shaping up to be the best month of the year so far. In fact, according to Lori Calvasina, Head of U.S. Equity Strategy at investment firm RBC, there’s a real possibility it’s generally up from here, or at least, the bottom could be very near. “If the US economy is headed for the economic scenario that’s currently embedded in consensus forecasts, or a relatively short and shallow recession that begins in 2H22 and wraps up

The Federal Reserve delivered a huge rate hike, but the Dow Jones extended gains after Jerome Powell said another huge hike may or may not come in September.

Shares of Teladoc Inc. were plunging more than 11% in after-hours trading Thursday after the telehealth company took another multibillion-dollar impairment charge, helping to bring its total losses for the first six months of the year up to nearly $10 billion.

Yahoo Finance tech correspondent Dan Howley analyzes Meta's second-quarter earnings miss and the social media company's reported decline in monthly active users for Facebook and Instagram.

U.S. stocks surged Wednesday as investors mulled a major decision from Federal Reserve policymakers to raise interest rates by 0.75% and remarks from Chair Jerome Powell hinting the central back may slow the pace of its rate-hiking cycle.

A historically high U.S. inflation rate of 9.1% hasn't stopped the Oracle of Omaha from putting his company's cash to work in five stocks.

The Senate just passed a $280B package of chip subsidies and research funding. Take advantage.

The odds are good that June 16 marked the stock market’s low, and we are in the early stages of a new bull market. Inflation is rolling over. Supply chains are repairing. There is enough terror in the market to suggest we are near the bottom.

Investors were hoping for a strong earnings outlook from Ford Motor They got it—and the stock is soaring. Operating profit margins came in at 9.3%, up from 6.7% in the first quarter of 2022 and up from 3.9% in the second quarter of 2021. “We’re moving with purpose and speed into the most promising period for growth in Ford’s history,” said CEO Jim Farley.

It might finally be time for Cathie Wood's investing style to shine again. The CEO and co-founder of Ark Invest has been bouncing back lately. Her largest exchange-traded fund (ETF) is up 24% since bottoming out two months ago, and some of her smaller funds are faring even better.

Notable business headlines include pharmaceutical company Teva reaching an opioid settlement, Credit Suisse naming Ulrich Koerner as the company's new CEO, and Twitter holding a shareholder meeting to vote on the $44 billion Elon Musk merger.

When she was in her 20’s, my sister and her husband accumulated a lot of credit-card debt, which my parents paid off (twice). In consideration of the fact that my sister paid off the credit-card debt, my parents set up the company so that I had a slight majority of the shares.

Dividend stocks are the Swiss army knives of the stock market. When dividend stocks go up, you make money. When they don’t go up — you still make money (from the dividend). Heck, even when a dividend stock goes down in price, it’s not all bad news, because the dividend yield (the absolute dividend amount, divided by the stock price) gets richer the more the stock falls in price. Knowing all this, wouldn’t you like to own find great dividend stocks? Of course you would! Using the TipRanks platfor

"We're putting increased energy and focus around our key company priorities that unlock both near and long term opportunities for Meta," said CEO Mark Zuckerberg.

DEEP DIVE In December, we listed analysts’ favorite semiconductor stocks for 2022. That hasn’t turned out well. But after chipmakers’ stocks have been hammered, the group is now trading at “normal-level valuations,” according to Matt Peron, director of research at Janus Henderson Investors.